MicroRNA-497 inhibits cardiac hypertrophy by targeting Sirt4

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Xiao, Yimin ^a,b   Zhang, Xiaofei ^a,b   Fan, Shihao ^a,b   Cui, Guanghao ^a   Shen, Zhenya ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Shanghai YODAK Cardio Thoracic Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; MICRORNA; MICRORNA 497; SIRTUIN 4; UNCLASSIFIED DRUG; MIRN497 MICRORNA, MOUSE; MITOCHONDRIAL PROTEIN; SIRT4 PROTEIN, MOUSE; SIRTUIN;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; HEART FUNCTION; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MOUSE; NEWBORN; NONHUMAN; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CARDIOMEGALY; CELL CULTURE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICE; MICE, INBRED C57BL; MICRORNAS; MITOCHONDRIAL PROTEINS; MYOCARDIUM; MYOCYTES, CARDIAC; SIRTUINS;

EID: 85006721007     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0168078     Document Type: Article

References (21)

1. Mukku RB, Fonarow GC, Watson KE, Ajijola OA, Depasquale EC, Nsair A, et al. Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy. Journal of cardiac failure. 2016; 22 (6):439-48. doi: 10.1016/j.cardfail.2016.04.009 PMID: 27109619
2. Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. Journal of molecular and cellular cardiology. 2016.
3. Ono K. microRNAs and Cardiovascular Remodeling. Advances in experimental medicine and biology. 2015; 888:197-213. doi: 10.1007/978-3-319-22671-2-10 PMID: 26663184
4. Vegter EL, van der Meer P, de Windt LJ, Pinto YM, Voors AA. MicroRNAs in heart failure: from biomarker to target for therapy. European journal of heart failure. 2016; 18(5):457-68. doi: 10.1002/ejhf. 495 PMID: 26869172
5. Potter GD, Burlingame SM, Cragoe EJ, Sellin JH. Electrogenic sodium transport in the developing rabbit cecum. Journal of pediatric gastroenterology and nutrition. 1989; 8(4):516-21. PMID: 2723943
6. Liu Q, Wang H, Singh A, Shou F. Expression and function of microRNA-497 in human osteosarcoma. Molecular medicine reports. 2016; 14(1):439-45. doi: 10.3892/mmr.2016.5256 PMID: 27176490
7. Ge L, Zheng B, Li M, Niu L, Li Z. MicroRNA-497 suppresses osteosarcoma tumor growth and. Oncology letters. 2016; 11(3):2207-12. PubMed Central PMCID: PMC4774554. doi: 10.3892/ol.2016.4162 PMID: 26998150
8. Liu J, Zhou Y, Shi Z, Hu Y, Meng T, Zhang X, et al. microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7. DNA and cell biology. 2016.
9. Tijsen AJ, van der Made I, van den Hoogenhof MM, Wijnen WJ, van Deel ED, de Groot NE, et al. The microRNA-15 family inhibits the TGFbeta-pathway in the heart. Cardiovascular research. 2014; 104 (1):61-71. doi: 10.1093/cvr/cvu184 PMID: 25103110
10. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation. 1998; 98(13):1329-34. PMID: 9751683
11. Kamo T, Akazawa H, Komuro I. Cardiac nonmyocytes in the hub of cardiac hypertrophy. Circulation research. 2015; 117(1):89-98. doi: 10.1161/CIRCRESAHA.117.305349 PMID: 26089366
12. Greco CM, Condorelli G. Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure. Nature reviews Cardiology. 2015; 12(8):488-97. doi: 10.1038/nrcardio.2015.71 PMID: 25962978
13. Lv D, Liu J, Zhao C, Sun Q, Zhou Q, Xu J, et al. Targeting microRNAs in Pathological Hypertrophy and Cardiac Failure. Mini reviews in medicinal chemistry. 2015; 15(6):475-8. PMID: 25807942
14. Yang L, Li Y, Wang X, Mu X, Qin D, Huang W, et al. Overexpression of miR-223 Tips the Balance of Pro- and Anti-Hypertrophic Signaling Cascades toward Physiologic Cardiac Hypertrophy. The Journal of biological chemistry. 2016.
15. Raut SK, Singh GB, Rastogi B, Saikia UN, Mittal A, Dogra N, et al. miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy. Molecular and cellular biochemistry. 2016; 417(1-2):191-203. doi: 10.1007/s11010-016-2729-7 PMID: 27221738
16. Sun X, Zhang C. MicroRNA-96 promotes myocardial hypertrophy by targeting mTOR. International journal of clinical and experimental pathology. 2015; 8(11):14500-6. PubMed Central PMCID: PMC4713555. PMID: 26823769
17. Li X, Zeng Z, Li Q, Xu Q, Xie J, Hao H, et al. Inhibition of microRNA-497 ameliorates anoxia/reoxygenation injury in cardiomyocytes by suppressing cell apoptosis and enhancing autophagy. Oncotarget. 2015; 6(22):18829-44. PubMed Central PMCID: PMC4643066. doi: 10.18632/oncotarget.4774 PMID: 26299920
18. Zhu Y, Yan Y, Principe DR, Zou X, Vassilopoulos A, Gius D. SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis. Cancer & metabolism. 2014; 2:15. PubMed Central PMCID: PMC4203689.
19. Verdin E, Hirschey MD, Finley LW, Haigis MC. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends in biochemical sciences. 2010; 35(12):669-75. PubMed Central PMCID: PMC2992946. doi: 10.1016/j.tibs.2010.07.003 PMID: 20863707
20. Luo YX, Tang X, An XZ, Xie XM, Chen XF, Zhao X, et al. Sirt4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity. European heart journal. 2016.
21. Tarantino G, Finelli C, Scopacasa F, Pasanisi F, Contaldo F, Capone D, et al. Circulating levels of sirtuin 4, a potential marker of oxidative metabolism, related to coronary artery disease in obese patients suffering from NAFLD, with normal or slightly increased liver enzymes. Oxidative medicine and cellular longevity. 2014; 2014:920676. PubMed Central PMCID: PMC4086623. doi: 10.1155/2014/920676 PMID: 25045415